MLchartDataset catalogue

belapectin

Term · Oncology and biomedicine · MLC-T-ONC-011939

A carbohydrate-based galectin inhibitor, with potential antineoplastic activity. Belapectin binds to the carbohydrate-binding domain of galectins, especially galectin-3, and may result in an induction of apoptosis mediated through activation of both mitochondria and caspases. This may reduce tumor growth in galectin-overexpressing tumor cells. Galectins, often overexpressed on tumor cells, play a key role in cancer cell proliferation, apoptosis, tumor angiogenesis and evasion of immune responses.

Table 1. Record
IdentifierMLC-T-ONC-011939
FieldOncology and biomedicine
Synonymsgalactoarabino-rhamnogalacturonate
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011939",
  "term": "belapectin",
  "field": "Oncology and biomedicine",
  "definition": "A carbohydrate-based galectin inhibitor, with potential antineoplastic activity. Belapectin binds to the carbohydrate-binding domain of galectins, especially galectin-3, and may result in an induction of apoptosis mediated through activation of both mitochondria and caspases. This may reduce tumor growth in galectin-overexpressing tumor cells. Galectins, often overexpressed on tumor cells, play a key role in cancer cell proliferation, apoptosis, tumor angiogenesis and evasion of immune responses.",
  "synonyms": [
    "galactoarabino-rhamnogalacturonate"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/belapectin/"
}

Record 3,401 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.